Combined Treatment With Leuprolide Acetate and Burosumab in X-linked Hypophosphatemia and Precocious Puberty: A Therapeutic Response

Combined Treatment With Leuprolide Acetate and Burosumab in X-linked Hypophosphatemia and Precocious Puberty: A Therapeutic Response

Background/Objective: Individuals with X-linked hypophosphatemia (XLH) generally experience normal puberty. However, the prevalence of central precocious puberty (CPP) in patients with XLH seems to be similar to that of the general population, and CPP may similarly impact their predicted final heigh...

Full description

Saved in:
Bibliographic Details
Main Authors: Gustavo Tempone Cardoso Penna, MS, Carolina Costa Figueiredo, MD, MSc, Nara Michelle de Araújo Evangelista, MD, MSc, Vânia de Fátima Tonetto Fernandes, MD, PhD, Patricia Salmona, MD, Guido de Paula Colares Neto, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:AACE Clinical Case Reports
Subjects:
burosumab
central precocious puberty
leuprolide acetate
X-linked hypophosphatemia
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060524001020
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items